[EN] ENOL CARBAMATE DERIVATIVES AS MODULATORS OF FATTY ACID AMIDE HYDROLASE<br/>[FR] DÉRIVÉS CARBAMATES D'ÉNOL EN TANT QUE MODULATEURS DE L'HYDROLASE D'AMIDES D'ACIDES GRAS
申请人:SIGMA TAU IND FARMACEUTI
公开号:WO2009109504A1
公开(公告)日:2009-09-11
The invention provides novel enol carbamate derivatives of formula (I) for inhibiting Fatty Acid Amide Hydrolase (FAAH), compositions that include such compounds as well as methods of treating diseases of energy metabolism, central nervous system disorders, cardiovascular and respiratory disorders, retinopathy, cancer, gastrointestinal and liver disorders and/or musculoskeletal disorders. The compounds of the present invention proved particularly efficacious in animal models of anxiety and pain.
该发明提供了一种用于抑制脂肪酸酰胺水解酶(FAAH)的新型烯醇氨基甲酸酯衍生物的化学式(I),包括这些化合物的组合物以及治疗能量代谢疾病、中枢神经系统疾病、心血管和呼吸系统疾病、视网膜病变、癌症、胃肠道和肝脏疾病和/或肌肉骨骼疾病的方法。本发明的化合物在动物模型中表现出特别有效的抗焦虑和止痛作用。